PT Indofarma Tbk (IDX:INAF)

PT Indofarma Tbk Revenue

PT Indofarma Tbk had revenue of 54.99B IDR in the quarter ending September 30, 2026, a decrease of -17.56%. This brings the company's total for the last twelve months to 151.85B, down -26.37% year-over-year. In the year 2025, PT Indofarma Tbk had annual revenue of 151.55B, down -27.96%. That makes PT Indofarma Tbk the 38,133rd largest company in the world by revenue and 694th in Indonesia.

• Revenue (ttm): 151.85B
• Revenue Growth: -26.37%
• P/S Ratio: 2.57
• Revenue / Employee: 3.62B
• Employees: 42
• Market Cap: 390.51B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine 79.80B 52.7%
• Medical Devices & Others 71.75B 47.3%

By Geography

Chart

• Indonesia 134.90B 89.0%
• Export 16.65B 11.0%

Fiscal year ended Dec 31, 2025 See the full PT Indofarma Tbk breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	151.55B	-58.83B	-27.96%
Dec 31, 2024	210.38B	-313.22B	-59.82%
Dec 31, 2023	523.60B	-456.77B	-46.59%
Dec 31, 2022	980.37B	-1.92T	-66.22%
Dec 31, 2021	2.90T	1.19T	69.15%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error